IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v8y2017i1d10.1038_ncomms15507.html
   My bibliography  Save this article

Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy

Author

Listed:
  • Yu-Cheng Su

    (Institute of Biomedical Sciences, Academia Sinica)

  • Pierre-Alain Burnouf

    (Institute of Biomedical Sciences, Academia Sinica
    Taiwan International Graduate Program in Molecular Medicine, National Yang-Ming University and Academia Sinica)

  • Kuo-Hsiang Chuang

    (Graduate Institute of Pharmacognosy, Taipei Medical University)

  • Bing-Mae Chen

    (Institute of Biomedical Sciences, Academia Sinica)

  • Tian-Lu Cheng

    (Center for Biomarkers and Biotech Drugs, Kaohsiung Medical University)

  • Steve R. Roffler

    (Institute of Biomedical Sciences, Academia Sinica
    Graduate Institute of Medicine, Kaohsiung Medical University)

Abstract

Triple-negative breast cancer (TNBC) lacks effective treatment options due to the absence of traditional therapeutic targets. The epidermal growth factor receptor (EGFR) has emerged as a promising target for TNBC therapy because it is overexpressed in about 50% of TNBC patients. Here we describe a PEG engager that simultaneously binds polyethylene glycol and EGFR to deliver PEGylated nanomedicines to EGFR+ TNBC. The PEG engager displays conditional internalization by remaining on the surface of TNBC cells until contact with PEGylated nanocarriers triggers rapid engulfment of nanocargos. PEG engager enhances the anti-proliferative activity of PEG-liposomal doxorubicin to EGFR+ TNBC cells by up to 100-fold with potency dependent on EGFR expression levels. The PEG engager significantly increases retention of fluorescent PEG probes and enhances the antitumour activity of PEGylated liposomal doxorubicin in human TNBC xenografts. PEG engagers with specificity for EGFR are promising for improved treatment of EGFR+ TNBC patients.

Suggested Citation

  • Yu-Cheng Su & Pierre-Alain Burnouf & Kuo-Hsiang Chuang & Bing-Mae Chen & Tian-Lu Cheng & Steve R. Roffler, 2017. "Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy," Nature Communications, Nature, vol. 8(1), pages 1-12, August.
    • Handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15507
    DOI: 10.1038/ncomms15507
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms15507
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms15507?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15507. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.